IN2014DN08198A - - Google Patents

Info

Publication number
IN2014DN08198A
IN2014DN08198A IN8198DEN2014A IN2014DN08198A IN 2014DN08198 A IN2014DN08198 A IN 2014DN08198A IN 8198DEN2014 A IN8198DEN2014 A IN 8198DEN2014A IN 2014DN08198 A IN2014DN08198 A IN 2014DN08198A
Authority
IN
India
Prior art keywords
crystal form
compounds
parameters
androsta
triol
Prior art date
Application number
Inventor
Suizhen Lin
Jingxia Zhang
Xinhua Li
Original Assignee
Guangzhou Celprotek Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46557937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guangzhou Celprotek Pharmaceutical Co Ltd filed Critical Guangzhou Celprotek Pharmaceutical Co Ltd
Publication of IN2014DN08198A publication Critical patent/IN2014DN08198A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0007—Androstane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

Disclosed are four compounds of crystal form of androsta-¾5a,6p-triol (YC-6 for short) (YC-6 of A crystal form, YC-6 of B crystal form, YC-6 of C crystal form, YC-6 of D crystal form) and a method for preparing same. The four compounds of crystal form are characterized b y remarkable differences in parameters such as lattice parameters, 2Θ and intensity of X-ray powder diffraction, melting point, etc. Study on the polymorphism is significant for further researching the pharmaceutical effect, bioavailability and stability thereof.
IN8198DEN2014 2012-03-08 2012-04-11 IN2014DN08198A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210060611.6A CN102617685B (en) 2012-03-08 2012-03-08 Crystal form compounds of androstane-3beta,5alpha,6beta-triol and preparation method thereof
PCT/CN2012/073854 WO2013131305A1 (en) 2012-03-08 2012-04-11 Compound of crystal form of androsta-3β,5α,6β-triol and method for preparing same

Publications (1)

Publication Number Publication Date
IN2014DN08198A true IN2014DN08198A (en) 2015-05-01

Family

ID=46557937

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8198DEN2014 IN2014DN08198A (en) 2012-03-08 2012-04-11

Country Status (13)

Country Link
US (3) US9688716B2 (en)
EP (2) EP3112374A1 (en)
JP (1) JP2015511587A (en)
KR (1) KR20150002653A (en)
CN (4) CN103626818B (en)
AU (1) AU2012372640B2 (en)
CA (2) CA2909998A1 (en)
IL (1) IL234492A (en)
IN (1) IN2014DN08198A (en)
RU (1) RU2608894C2 (en)
SG (1) SG11201405376TA (en)
TW (1) TW201336861A (en)
WO (1) WO2013131305A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2873004A1 (en) * 2012-05-07 2013-11-14 The Procter & Gamble Company Flexible materials for flexible containers
CN109985048B (en) * 2017-12-29 2021-06-29 广州市赛普特医药科技股份有限公司 2 beta, 3 alpha, 5 alpha-trihydroxyandrost-6-one for the treatment of inflammatory reactions
US11532903B2 (en) * 2021-04-01 2022-12-20 Ideal Industries, Inc. Universal electrical connector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191576A (en) * 1936-11-21 1940-02-27 Soc Of Chemical Ind 3,5,6-trihydroxy androstane and pregnane compounds
US2191578A (en) 1939-07-24 1940-02-27 Crosley Corp Ice-cream tray
ATE15206T1 (en) * 1981-09-21 1985-09-15 Schering Ag 3-BETA,7-BETA,15-ALPHA-TRIHYDROXY-5-ANDROSTENE-1 - ONE, THEIR 3,15-TRIMETHYLACETIC ACID ESTERS AND THEIR PRODUCTION.
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
CN101884638B (en) 2010-07-09 2011-11-09 中山大学 Application of 5alpha-androstane-3beta,5,6beta-triol in preparing neuro-protective medicaments
CN101961311B (en) 2010-09-21 2012-11-21 中山大学 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof
CN102180928B (en) * 2011-03-15 2013-01-16 广州市赛普特医药科技有限公司 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof

Also Published As

Publication number Publication date
US9944672B2 (en) 2018-04-17
KR20150002653A (en) 2015-01-07
CN103626818A (en) 2014-03-12
JP2015511587A (en) 2015-04-20
CN103626819B (en) 2016-01-20
RU2608894C2 (en) 2017-01-26
CN102617685B (en) 2014-01-22
SG11201405376TA (en) 2014-11-27
US20170305958A1 (en) 2017-10-26
AU2012372640A1 (en) 2014-09-25
EP3112374A1 (en) 2017-01-04
EP2889303A1 (en) 2015-07-01
RU2014136891A (en) 2016-05-10
IL234492A (en) 2017-02-28
WO2013131305A1 (en) 2013-09-12
EP2889303A4 (en) 2016-02-17
US20170305957A1 (en) 2017-10-26
CA2909998A1 (en) 2013-09-12
CN103626818B (en) 2016-03-30
US9944673B2 (en) 2018-04-17
CN103626817A (en) 2014-03-12
CA2866398C (en) 2016-06-28
CN103626817B (en) 2016-01-20
TW201336861A (en) 2013-09-16
CN103626819A (en) 2014-03-12
CA2866398A1 (en) 2013-09-12
CN102617685A (en) 2012-08-01
AU2012372640B2 (en) 2015-07-09
US20150045566A1 (en) 2015-02-12
US9688716B2 (en) 2017-06-27

Similar Documents

Publication Publication Date Title
MX2016012419A (en) Ibrutinib solid forms and production process therefor.
ZA201503125B (en) One-pot method for the synthesis of cu-ssz-13, the compound obtained by the method and use thereof
HK1203506A1 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
EP2996963A4 (en) Capsule for preparing consumable product
HK1202709A1 (en) Process for preparing crystalline electrode materials and materials obtained therefrom
HRP20181333T1 (en) Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same
EP3049185A4 (en) Process for the recovery of components forming a metal-organic framework material
WO2014141292A3 (en) Endoxifen citrate polymorph and process for preparing the same
ZA201500009B (en) Process for the production of crystalline titanium powder
EP2857562A4 (en) SiC SINGLE-CRYSTAL INGOT, SiC SINGLE CRYSTAL, AND PRODUCTION METHOD FOR SAME
EP2886192A4 (en) Hydrothermal synthesis apparatus and method for preparing cathode active material using same
EP3230204A4 (en) A novel method for carbonizing lignocelluosic material as a powder
EP2692908B8 (en) Method for the production of ingots
EP3042904A4 (en) Method for preparing improved intermediate for producing high-purity pemetrexed and method for producing high-purity pemetrexed using intermediate
IN2014DN08198A (en)
IL245260B (en) A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
IL242897A0 (en) Process for preparing pyridylpyrazole compounds and derivatives thereof from pyridylhydrazine
WO2013121439A3 (en) Garenoxacin mesylate, process for preparation thereof, and crystalline form thereof.
EP3248938A4 (en) Production method for carbon material using crucible
ZA201409488B (en) Method for preparing ual2 powder and uai2 powder prepared according to the same
IN2013MU03508A (en)
IN2013MU02528A (en)
ZA201406287B (en) Process for preparing diketonato-rhodium(i)-carbonyl complexes
EP2832709A4 (en) Process for producing inorganic-fiber-bonded ceramic material
MX2017015505A (en) Composition of pranlukast-containing solid preparation with improved bioavailability and method for preparing same.